What's happening
This bill amends cannabis laws to clarify THC definitions, regulate cannabinoid hemp retail sales, and establish new labeling requirements for hemp-derived products.
Why it matters
Narrows THC Definitions. By specifying that “THC” and “Total THC” now only refer to Delta-9-tetrahydrocannabinol, the bill clarifies legal distinctions between different cannabinoids. This could impact which products are considered legal or regulated, closing loopholes around Delta-8 and Delta-10 variants that are popular in the hemp industry.
Expands Retail Access for Smokable Hemp. The bill removes the restriction that smokable hemp flower products be sold only in adult-use cannabis dispensaries, allowing broader retail access as long as customers are 21 or older. This may increase consumer availability and market competition but could also raise public health and youth access concerns.
Mandates Stricter Labeling Standards. New requirements for hemp-derived cannabinoid products include nutrition labels, clear warnings about lack of FDA regulation and medical benefits, milligram content per serving, and manufacturer/distributor addresses. These measures aim to improve consumer transparency and safety, helping buyers make informed choices and deterring misleading health claims.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Regulate Hemp Retail Labeling
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to investigations and government operations
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
9165
IN SENATE
May 11, 2022
Introduced by Sen. SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Investigations and Government Operations
AN ACT to amend the cannabis law, in relation to cannabinoid hemp retail sales and retailers
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivisions 52 and 53 of section 3 of the cannabis law are amended to read as follows:
52. "THC" means Delta-9-tetrahydrocannabinol[; Delta-8-tetrahydrocannabinol; Delta-10-tetrahydrocannabinol and the optical isomer of such substances].
53. "Total THC" means the [sum of the percentage by weight or volume measurement of tetrahydrocannabinolic acid multiplied by 0.877, plus, the percentage by weight or volume measurement of THC] dry weight total percentage of Delta-9-tetrahydrocannabinol in each product.
§ 2. The opening paragraph and subdivision 13 of section 91 of the cannabis law is amended to read as follows:
The board, without infringing on licensed retailers, may make regulations pursuant to this article for the processing, distribution, marketing, transportation and sale of cannabinoid hemp and hemp extracts used for human consumption, which may include, but not be limited to:
13. Any cannabinoid hemp flower product clearly labeled or advertised for the purposes of smoking, or in the form of a cigarette, cigar, or pre-roll, or packaged or combined with other items designed to facilitate smoking such as rolling papers or pipes, shall only be offered for sale [in adult-use cannabis retail dispensaries licensed pursuant to article four of this chapter] to those individuals twenty-one years of age and older.
§ 3. Subdivision 2 of section 103 of the cannabis law is amended to read as follows:
2. The board may, by rules and regulations, require processors to establish a code, including, but not limited to QR code, for labels and establish methods and procedures for determining, among other things,
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD15682-01-2
serving sizes or dosages for cannabinoid hemp, hemp extract and products derived therefrom, active cannabinoid concentration per serving size, number of servings per container, and the growing region, state or country of origin if not from the United States. Such rules and regulations may require an appropriate fact panel that incorporates data regarding serving sizes and potency thereof; provided, however, and notwithstanding any statute, rule, or regulation to the contrary, all hemp-derived cannabinoid products shall meet the following labeling requirements:
(a) a nutrition label with serving size;
(b) a warning label that the product is not meant to treat or cure any medical ailment and that such product is not regulated by the FDA;
(c) the amount of hemp derived product in each serving of the product in milligrams; and
(d) the address of the manufacturer or distributor.
§ 4. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the cannabis law, in relation to cannabinoid hemp retail sales and retailers
Purpose
The legislation will ensure that licensed hemp dealers are allowed to distribute and/or sell hemp-derived cannabinoid products so long as those products meet the definition of cannabinoid hemp in Article 5 of the MRTA.
Summary of provisions
MRTA Article 1, Section 3, subsections 52 and 53 are amended by altering the definitions to better reflect federal regulations to which they now read:
Read the full memo (627 words)
52. "THC" means Delta-9-tetrahydrocannabinol
53. "Total THC" means the dry weight total percentage of Delta-9-tetrah- ydrocannabinol in each product.
MRTA Article 5, Section 91 is amended to add new subsection two (2) which shall read: Commencing on January 1, 2023, a CBD retailer licensed by the Office of Cannabis Management pursuant to this Article or appli- cable rule shall be permitted to sell any and all forms of Cannabinoid Hemp provided that such forms of Cannabinoid Hemp meet the requirements set forth in this article. The Board shall have the authority to promul- gate any rules necessary to ensure the safety of Cannabinoid Hemp, so long as said rules do not infringe upon the ability of licensed hemp retailers to sell Cannabinoid Hemp. Any prior or future rules, poli- cies, or regulations promulgated by the board or any other rulemaking body to prohibit the selling of any form of cannabinoid hemp shall become null and void.
MRTA Article 5, Section 91, subsection 14 is amended to remove the following language: in adult-use cannabis retail dispensaries licensed pursuant to article four of this chapter.
This language is replaced with the following: to those individuals 21 years of age and older.
MRTA Article 5, Section 103 is amended to add new subsection two (2) which shall read:
Notwithstanding any statute, rule, or regulation to the contrary, all hemp-derived cannabinoid products must meet the following labeling requirements:
(1) Nutrition label with serving size
(2) Warning label that the product is not meant to treat or cure any medical ailment and that it is not regulated by the FDA.
(3) Amount of hemp derived product in each serving of the product in milligrams
(4) The address of the manufacturer or distributor.
Justification
Over the last several years, states across the country have ended the prohibition of hemp-derived cannabis products. New York has been no different as it recently legalized recreational marijuana and ended the prohibition of cannabis. However, recently enacted regulations by the Cannabis Control Board threaten to criminalize the sale of certain hemp- derived products. The decisions to make certain hemp-derived cannabi- noids illegal to distribute or sell in a licensed environment will once again turn law abiding citizens and business owners into criminals in the eyes of the state. This would greatly hinder the work being done to aid those disproportionately impacted communities most affected by the prohibition of cannabis.
There is no justification as to why licensed and regulated businesses should not be allowed to distribute or sell hemp-derived cannabinoid products in a safe manner. This bill would protect the free market of the hemp industry and ensure that the entirety of the hemp plant is available in the free market, and that a monopoly of cannabinoid hemp products does not arise within marijuana dispensaries.
Thus, this legislation will ensure greater public accessibility to cannabinoid hemp products , provided that those products are sold in a licensed and regulated manner. All cannabinoid hemp products that meet the definition in Article 5 of the MRTA should be permitted to be distributed or sold by licensed dealers, regardless if they are within hemp retail locations or marijuana dispensaries.
Legislative history
New Bill
Fiscal implications for state and local governments
None
Effective date
Immediately
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.